|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Allena Pharmaceuticals, Inc. (ALNA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Mon 12/11
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
38,290,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.000001 - $0.0009 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Allena Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing oral enzyme therapeutics to treat patients with metabolic and kidney disorders. Co. is focused on metabolic disorders that result in excess accumulation of certain metabolites that stimulate inflammation, damage the kidney, and potentially lead to chronic kidney disease (CKD), and end-stage renal disease. Co.'s product candidate, ALLN-346, is an orally administered, urate degrading enzyme for patients with hyperuricemia and gout in the setting of improved CKD. Co. has conducted a Phase 1 program, including both a single-ascending dose and multiple-ascending dose study in healthy volunteers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Brenner Louis Md |
President and CEO |
• • – |
2021-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
125,582 |
328,904 |
|
- |
|
| Brenner Louis Md |
President and CEO |
• • – |
2021-11-15 |
4 |
S |
$0.81 |
$32,666 |
D/D |
(40,328) |
288,576 |
|
71% |
|
| Brenner Louis Md |
President and COO |
• – – |
2021-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
83,721 |
228,537 |
|
- |
|
| Brenner Louis Md |
President and COO |
• – – |
2021-05-10 |
4 |
S |
$1.11 |
$27,989 |
D/D |
(25,215) |
203,322 |
|
12% |
|
| Fitzpatrick Mark J. |
Director |
– • – |
2021-04-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
-24% |
|
| Wholihan Edward |
Chief Financial Officer |
• – – |
2020-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
164,822 |
189,822 |
|
- |
|
| Wholihan Edward |
Chief Financial Officer |
• – – |
2020-12-17 |
4 |
S |
$1.36 |
$93,228 |
D/D |
(68,550) |
121,272 |
|
13% |
|
| Brenner Louis Md |
President and CEO |
• – – |
2020-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
247,932 |
247,932 |
|
- |
|
| Brenner Louis Md |
President and CEO |
• – – |
2020-12-17 |
4 |
S |
$1.36 |
$140,238 |
D/D |
(103,116) |
144,816 |
|
13% |
|
| Wholihan Edward |
Chief Financial Officer |
• – – |
2018-05-09 |
4 |
OE |
$1.59 |
$39,750 |
D/D |
25,000 |
25,000 |
|
- |
|
| Hbm Biocapital Ii Lp |
10% Owner |
– – • |
2017-11-06 |
4 |
B |
$14.00 |
$999,992 |
D/D |
71,428 |
1,638,330 |
2.45 |
- |
|
| Hbm Biocapital Ii Lp |
10% Owner |
– – • |
2017-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,566,902 |
1,566,902 |
|
- |
|
| Hadley Harbor Master Investors (cayman) L.p. |
10% Owner |
– – • |
2017-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
757,684 |
757,684 |
|
- |
|
| Tepper Robert I |
Director |
– • • |
2017-11-06 |
4 |
B |
$14.00 |
$3,010,000 |
D/D |
215,000 |
2,790,964 |
3.92 |
- |
|
| Tepper Robert I |
Director |
– • • |
2017-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,575,964 |
2,575,964 |
|
- |
|
| Topper James N |
Director |
– • • |
2017-11-06 |
4 |
B |
$14.00 |
$7,000,000 |
I/I |
500,000 |
3,330,373 |
2.25 |
- |
|
| Topper James N |
Director |
– • • |
2017-11-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,830,373 |
2,830,373 |
|
- |
|
| Frazier Healthcare Vi, L.p. |
10% Owner |
– – • |
2017-11-06 |
4 |
B |
$14.00 |
$7,000,000 |
I/I |
500,000 |
3,330,373 |
1.5 |
- |
|
| Frazier Healthcare Vi, L.p. |
10% Owner |
– – • |
2017-11-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,830,373 |
2,830,373 |
|
- |
|
| Starr Kevin P |
10% Owner |
– – • |
2017-11-06 |
4 |
B |
$14.00 |
$3,010,000 |
D/D |
215,000 |
2,790,964 |
2.45 |
- |
|
| Starr Kevin P |
10% Owner |
– – • |
2017-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,575,964 |
2,575,964 |
|
- |
|
| Bessemer Venture Partners Vii Institutional L.p. |
10% Owner |
– – • |
2017-11-06 |
4 |
B |
$14.00 |
$504,000 |
I/I |
36,000 |
2,263,365 |
1.5 |
- |
|
| Bessemer Venture Partners Vii Institutional L.p. |
10% Owner |
– – • |
2017-11-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,227,365 |
2,227,365 |
|
- |
|
| Kraus Stephen |
Director |
– • – |
2017-11-06 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
0 |
2.02 |
- |
|
| Kraus Stephen |
Director |
– • – |
2017-11-06 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
0 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
